Identifying Polymorphism with In Situ Raman Spectroscopy at Screening Scale
Remove the Randomness from Single Crystal Growing
Tracking polymorph and crystal morphology
Salt Screening with the Crystal16
Polymer Applications
Fast Track to Return on Investment
Crystallization Screening
Physical Stability of Agrochemical Formulations and Observation of Eutectics
Solubility-based Approach for Co-crystallization
Workshop “16 years of Crystal16” – Sophie Janbon (AstraZeneca)
Workshop “16 years of Crystal16” – Dr. Olivier Monnier (Sanofi R&D)
Workshop “16 years of Crystal16” – Dr. Joop H. ter Horst (University of Strathclyde)
Workshop “16 years of Crystal16” – Dr. Ivan Marziano (Pfizer UK)
Parenteral Formulations
Co-crystals: a perspective on current practices
Stability of Protein Formulations and Their Importance
A Scientist’s Guide to Crystallisation Process Development
Multi Component Pharmaceuticals: From Solid Form Screening to Controlled Crystallisation
